Novartis agrees $3bn deal to buy heart drug biotech from Blackstone
- Posted on February 11, 2025
- By Financial Times
- 1 Views
Novartis agrees $3bn deal to buy heart drug biotech from Blackstone
Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019
